SpeedWeed

MAY 4, 2021

Last week was eventful for cannabis reform in Texas, as the House of Representatives approved three legislative proposals, which would expand the state’s medical cannabis program, reduce penalties for concentrates and decriminalize possession. 1535 would also raise the THC limit in medical cannabis from 0.5%

Programs 52

Programs Chronic Pain Concentrates THC 52

NORML

FEBRUARY 1, 2019

And officials in San Francisco, California are considering a proposal to allow marijuana to be socially consumed and sold at temporary events. Click here to email your lawmakers in support of protecting compassionate care programs. Legislation is pending, SF 104, to expand Iowa’s narrow medical cannabidiol (CBD) law.

Legislation 162

Legislation Decriminalization Access Patients 162

MMJ Recs

MARCH 25, 2022

Patient drives are like pop-up day events, during which many people can avail of quick and easy appointments for MMJ cards if they have a qualifying condition. There may be other qualifying conditions for a NY MMJ card. These can be discussed during your consultation with a licensed MMJRecs NY state physician.

Patients 52

Patients Conditions Chronic Pain Dispensary 52

Cannabis Law Report

OCTOBER 17, 2019

Tree of Knowledge will be introducing chronic pain management protocols and research into the Caribbean market. The introduction of these protocols will take the form of clinical trials and research that will include the usage of specific strains of cannabis that aid in chronic pain and cancer treatments.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain CBD 40

MMJ Recs

OCTOBER 2, 2023

Today we’re here to explore the best medical marijuana dispensaries in California, as well as provide guidance on how to obtain a medical marijuana card, relevant state laws, the difference between recreational and medical marijuana, regulations governing medical cannabis, qualifying conditions, and the role of medical marijuana doctors.

Dispensary 52

Dispensary Patients Environment Conditions 52

Dykema (Cannabis Law Blog)

MARCH 25, 2020

Amidst claims of fraud and favoritism in Governor Quinn’s process, Governor Rauner’s staff undertook its own review of the cannabis business applications and, as a result, the State did not begin to grant business licenses until February 2015, or roughly 19 months after the Act was initially signed into law.

Chronic Pain 40

Chronic Pain Conditions Patients CBD 40

Cannabis Law Report

MAY 28, 2019

PUBLISHER: CANNABIS LAW REPORT. Thirty-three states and the District of Columbia have enacted medical marijuana programs. Veterans suffer widespread health problems including chronic pain, traumatic brain injuries, and post-traumatic stress disorder at a rate higher than the general population. May 2, 2019.

Access 49

Access Marijuana Research and Development Programs 49

Veriheal

JUNE 9, 2022

Unfortunately, the implementation of a medical cannabis program stalled abruptly the very next day when Governor Chris Christie took office. The patient registry for the medical cannabis program was not opened again until August 9th, 2012. New Jersey’s Medical Cannabis Program Continues to Evolve.

Recreational 21

Recreational Patients Programs Dispensary 21

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

NOVEMBER 9, 2021

KWC is a limited liability corporation formed under the laws of Arizona, which operates 10 ketamine infusion treatment clinics, across Arizona, Colorado, Florida, Illinois, Minnesota, Nevada, Texas, Utah, and Washington. Delic paid USD$3,293,933 and issued 241,258.50 multiple voting shares. Transaction Summary.

Treatment 52

Treatment Therapy Media Access 52

Cannabis Law Report

FEBRUARY 18, 2020

This guide will uncover key facts about recreational and medical marijuana use and the history of its laws in the state of New York. . Over the next 50 years, several studies surrounding marijuana use and its effects were conducted as the state introduced new laws. History of Marijuana Legislation in New York.

Marijuana 59

Marijuana Consumption Dispensary Vaping 59

Puff Puff Post

SEPTEMBER 16, 2019

Santé Cannabis, a pioneer in medical cannabis in Québéc , has partnered with Spectrum Therapeutics, the medical division of Canopy Growth (TSX: WEED) (NYSE: CGC) to launch the Prescriber Training Program, designed to aid physicians and patients, announced today at the new Santé Cannabis clinic and research centre in Montréal.

Programs 108

Programs Research and Development Education Treatment 108

Illinois News Joint

MAY 12, 2024

Chicago NORML Executive Director, Arianne Richards, then spoke as the only public commenter about the consideration for the new conditions, saying it was “imperative that these conditions be recognized as qualifying conditions” and emphasized “the importance of not categorizing these conditions solely under chronic pain.”

Conditions 84

Conditions Chronic Pain Patients Medicine 84

Cannabis Law Report

MARCH 19, 2020

FDA’s announcement comes on the heels of an active 2019, during which both FDA and the FTC issued warning letters to marketers of CBD products 1 and the plaintiffs’ bar began to actively file class-action lawsuits against marketers of CBD products under state law. Nonetheless, these products are widely available.

CBD 45

CBD Research and Development Seed-To-Sale Data 45

Puff Puff Post

SEPTEMBER 16, 2019

Santé Cannabis, a pioneer in medical cannabis in Québéc , has partnered with Spectrum Therapeutics, the medical division of Canopy Growth (TSX: WEED) (NYSE: CGC) to launch the Prescriber Training Program, designed to aid physicians and patients, announced today at the new Santé Cannabis clinic and research centre in Montréal.

Programs 40

Programs Research and Development Education Treatment 40

Cannabis Law Report

DECEMBER 20, 2021

About Epoladerm™ Virpax Pharmaceuticals is developing Epoladerm™ (diclofenac epolamine), an investigational analgesic supplied in a pre-filled device for administration as a topical spray film to manage chronic pain associated with osteoarthritis of the knee. Christopher M. Chipman, CPA. Chief Financial Officer.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Cannabis Law Report

SEPTEMBER 23, 2019

During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. The AAFP also recognizes that several states have passed laws approving limited recreational use and/or possession of marijuana. Cannabinoids have been assessed for chronic pain management.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

AUGUST 2, 2021

Study Results Indicate SCI-160 Has A Significant Analgesic Effect on Acute and Chronic Pain. Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

NOVEMBER 15, 2021

Our lead product candidate is Envelta™, which utilizes MET to deliver enkephalin nanoparticles for acute and chronic pain including pain associated with cancer. Probudur™ is a single injection long-acting liposomal bupivacaine formulation being developed to manage post-operative pain. TABLES FOLLOW.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

OCTOBER 11, 2021

The expansion of the Texas medical marijuana program is a sign that red state politicians understand the public’s shifting attitudes on marijuana. Starting in September 2021, state residents can enter the Texas medical marijuana program if they have cancer. However, the original bill to expand the law, filed by Republican Rep.

Patients 52

Patients Marijuana Chronic Pain Programs 52

MedicalJane

DECEMBER 13, 2017

Introduced in July 2014, New York’s medical marijuana program has been a work in progress from the get-go. The state recently announced an expansion to its program that is beginning to open the door to improved patient access. These changes included adding chronic pain and PTSD to its list of qualifying medical conditions.

Programs 49

Programs Patients Chronic Pain Marijuana 49

The Cannigma

OCTOBER 8, 2021

The United Kingdom legalized medical cannabis in November 2018 but the program is the subject of criticism regarding access to medicine and approval of patients. The laws on cannabis are covered in the country’s Misuse of Drugs Act of 1971 which lists a litany of regulations covering cannabis and other drugs.

Legalization 52

Legalization Medicine Conditions Patients 52

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma. how the segments are defined (e.g.,

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

DECEMBER 30, 2019

Over 60 cannabis-related bills were signed into law in states across the country. Illinois and the US territory of Guam legalized adult-use cannabis and its retail sale, medical cannabis programs were enacted and expanded in several states, and 27 states considered legislation that would have legalized adult-use cannabis, a record-high.

Legislation 59

Legislation Patients Access Banking 59